Anti–Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development

Autor:	Powles, Thomas, Necchi, Andrea, Rosen, Galit, Hariharan, Subramanian, Apolo, Andrea B.
Zdroj:	In Clinical Genitourinary Cancer April 2018 16(2):117-129
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect